Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
- PMID: 15671132
- DOI: 10.1177/0269881105048900
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
Abstract
This review of chronic tolerance to MDMA (3,4-methylenedioxymetamphetamine) covers the empirical data on dosage escalation, reduced subjective efficacy and bingeing in recreational Ecstasy users. Novice users generally take a single Ecstasy tablet, regular users typically take 2-3 tablets, whereas the most experienced users may take 10-25 tablets in a single session. Reduced subjective efficacy following repeated usage is typically described, with many users subjectively reporting the development of tolerance. Intensive self-administration or bingeing is often noted by experienced users. This can comprise 'stacking' on several tablets together, and 'boosting' on successive doses over an extended period. Some experienced users snort Ecstasy powder nasally, whereas a small minority inject MDMA. Chronic tolerance and bingeing are statistically linked to higher rates of drug-related psychobiological problems. In terms of underlying mechanisms, neuroadaptive processes are certainly involved, but there is a paucity of evidence on hepatic and behavioural mechanisms. Further studies specifically designed to investigate chronic tolerance, involving low intermittent dose regimens, are required. Most animal research has involved intensive MDMA dosing regimens designed to engender serotonergic neurotoxicity, and this may comprise another underlying mechanism. If distal serotonin axon terminal loss was also developing in recreational users, it may help to explain why reducing subjective efficacy, dosage escalation and increasing psychobiological problems often develop in parallel. In conclusion, there is extensive evidence for chronic pharmacodynamic tolerance to recreational Ecstasy/MDMA, but the underlying mechanisms are currently unclear. Several traditional processes are probably involved, but one of the possible causes is a novel mechanism largely unique to the ring substituted amphetamine derivatives, namely serotonergic neurotoxicity.
Similar articles
-
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
-
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research.Hum Psychopharmacol. 2001 Dec;16(8):557-577. doi: 10.1002/hup.351. Hum Psychopharmacol. 2001. PMID: 12404536
-
Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.Addict Behav. 2004 Jun;29(4):743-52. doi: 10.1016/j.addbeh.2004.02.022. Addict Behav. 2004. PMID: 15135556
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.Hum Psychopharmacol. 2002 Aug;17(6):309-12. doi: 10.1002/hup.415. Hum Psychopharmacol. 2002. PMID: 12404677
Cited by
-
Preventing new substance use behaviors in youth: evaluation of a two-year comprehensive program.Front Psychol. 2024 Jul 5;15:1339751. doi: 10.3389/fpsyg.2024.1339751. eCollection 2024. Front Psychol. 2024. PMID: 39035087 Free PMC article.
-
Development and Psychometric Properties of the Synthetic Drug Dependence Scale in a Chinese Sample.Front Psychol. 2021 Oct 26;12:717029. doi: 10.3389/fpsyg.2021.717029. eCollection 2021. Front Psychol. 2021. PMID: 34764905 Free PMC article.
-
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences.Front Pharmacol. 2021 Aug 27;12:713486. doi: 10.3389/fphar.2021.713486. eCollection 2021. Front Pharmacol. 2021. PMID: 34512343 Free PMC article.
-
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies.J Psychopharmacol. 2021 May;35(5):556-565. doi: 10.1177/0269881121998322. Epub 2021 Mar 30. J Psychopharmacol. 2021. PMID: 33781103 Free PMC article.
-
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA.Sci Transl Med. 2019 Dec 11;11(522):eaaw6435. doi: 10.1126/scitranslmed.aaw6435. Sci Transl Med. 2019. PMID: 31826983 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical